Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis

Save

Report Abuse

Description

The purpose of the study is to assess whether there is a correlation between imaging and histology with prognosis in patients with soft tissue and bone MC from the archives of the Rizzoli Orthopaedic Institute all the patients with a histological diagnosis of soft tissue or bone malignant myoepithelioma treated from 1998 to 2021

Targeted Conditions

Study Overview

Start Date
January 10, 2024
Completion Date
April 30, 2024
Enrollment
33
Date Posted
February 6, 2024
Accepts Healthy Volunteers?
No
Gender
All

Locations

Full Address
IRCCS Itituto Ortopedico Rizzoli
Bologna, BO 40136, Italy

Eligibility

Study Population
patients with soft tissue and bone MC
Minimum Age (years)
2
Eligibility Criteria
Inclusion Criteria:

Male and female patients treated at Rizzoli Orthopaedic Institute between 01 Jan 1998 and 31 Dec 2021
Age ≥ 2 years old
Diagnosis of soft tissue or bone malignant myoepithelioma (MC-SB)
Patients with available clinical and imaging data

Exclusion Criteria:

At least one inclusion criterion not met

Study Contact Info

Study Contact Name
Costantino Errani, MD
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Malignant Myoepithelioma of Bone and Soft Tissues: Diagnostic Imaging and Histology in Relation to Prognosis 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
No
FDA Regulated Device?
No
NCTid (if applicable)
NCT06244420